Advisor Group Holdings, Inc. Affimed N.V. Transaction History

Advisor Group Holdings, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.32 - $0.62 $3,104 - $6,014	-9,700 Reduced 18.79%	41,910 $25,000
Q3 2023 Nov 13, 2023	BUY	$0.46 - $0.65 $16,564 - $23,406	36,010 Added 230.83%	51,610 $24,000
Q2 2023 Aug 10, 2023	BUY	$0.57 - $1.08 $570 - $1,080	1,000 Added 6.85%	15,600 $9,000
Q1 2023 May 12, 2023	SELL	$0.66 - $1.29 $4,143 - $8,098	-6,278 Reduced 30.07%	14,600 $10,000
Q4 2022 Feb 10, 2023	BUY	$1.1 - $2.45 $10,234 - $22,794	9,304 Added 80.39%	20,878 $25,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.32 $3,477 - $5,889	1,774 Added 18.1%	11,574 $24,000
Q2 2022 Aug 10, 2022	BUY	$2.27 - $4.86 $1,890 - $4,048	833 Added 9.29%	9,800 $27,000
Q1 2022 May 04, 2022	BUY	$3.69 - $5.65 $20,542 - $31,453	5,567 Added 163.74%	8,967 $40,000
Q3 2021 Nov 05, 2021	BUY	$5.54 - $7.51 $476 - $645	86 Added 2.6%	3,400 $21,000
Q2 2021 Aug 02, 2021	BUY	$7.78 - $11.4 $3,998 - $5,859	514 Added 18.36%	3,314 $28,000
Q1 2021 May 13, 2021	BUY	$5.12 - $8.48 $1,536 - $2,544	300 Added 12.0%	2,800 $22,000
Q4 2020 Feb 10, 2021	BUY	$3.16 - $7.03 $7,900 - $17,575	2,500 New	2,500 $15,000
Q2 2020 Aug 14, 2020	SELL	$1.58 - $4.63 $671 - $1,967	-425 Closed	0 $0
Q1 2020 May 18, 2020	BUY	$1.44 - $3.02 $612 - $1,283	425 New	425 $1,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $520M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.